PERCEPTIVE ADVISORS LLC 13D and 13G filings for Aldeyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 6:52 pm Sale |
2025-04-03 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 4,875,851 8.200% |
-4,400,000 (-47.44%) |
Filing |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 9,275,851 15.600% |
682,265 (+7.94%) |
Filing |
| 2024-02-14 4:52 pm Unchanged |
2023-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,593,586 14.600% |
0 (Unchanged) |
Filing |
| 2023-10-18 6:07 pm Sale |
2023-10-16 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,593,586 14.700% |
-2,756,499 (-24.29%) |
Filing |
| 2023-02-14 2:33 pm Purchase |
2022-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 11,350,085 19.400% |
1,446,206 (+14.60%) |
Filing |
| 2022-02-14 3:45 pm Purchase |
2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 9,903,879 17.000% |
1,200,000 (+13.79%) |
Filing |
| 2021-02-16 3:31 pm Purchase |
2020-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,703,879 19.100% |
2,418,421 (+38.48%) |
Filing |
| 2020-07-13 4:30 pm Purchase |
2020-07-09 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 6,285,458 19.100% |
3,200,000 (+103.71%) |
Filing |